Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery

Journal of International Medical Research

Volumn 36, Issue 6, 2008, Pages 1235-1247

  von Dossow, V ^a   Luetz, A ^a   Haas, A ^a   Sawitzki, B ^a   Wernecke, K D ^b   Volk, H D ^a   Spies, Claudia D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SOSTANA GMBH   (Germany)

Author keywords

Cardiopulmonary bypass; Cell mediated immune response; Inflammation; Opioid; Suppressor of cytokine signalling 3

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONCANAVALIN A; DIPYRONE; ETOMIDATE; FENTANYL; FLUNITRAZEPAM; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MIDAZOLAM; PANCURONIUM BROMIDE; PIRITRAMIDE; PROPOFOL; REMIFENTANIL; SEVOFLURANE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INTERLEUKIN DERIVATIVE; INTRAVENOUS ANESTHETIC AGENT; PIPERIDINE DERIVATIVE; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ARTICLE; BOLUS INJECTION; CARDIOPULMONARY BYPASS; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DRUG DOSE TITRATION; DRUG MECHANISM; ELECTIVE SURGERY; EVENING DOSAGE; GENE EXPRESSION REGULATION; HUMAN; INFECTION RATE; INFLAMMATION; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; LENGTH OF STAY; PILOT STUDY; POSTOPERATIVE ANALGESIA; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PREMEDICATION; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; BLOOD; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZATION;

ANESTHETICS, INTRAVENOUS; CORONARY ARTERY BYPASS; CYTOKINES; FENTANYL; GENE EXPRESSION; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; PILOT PROJECTS; PIPERIDINES; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59649095497     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600610     Document Type: Article

References (36)

1. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232-244.
2. Laffey JG, Boylan JF, Cheng DCH: The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252.
3. Agnello D, Lankford CS, Bream I, et al: Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003; 23: 147-161.
4. Hirai S: Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 2003; 9: 365-370.
5. Franke A, Lante W, Fackeldey V, et al: Proinflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005; 28: 569-575.
6. Alexander WS, Hilton DJ: The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 2004; 22: 503-529.
7. Ilangumaran S, Ramanathan S, Rottapel R: Regulation of the immune system by SOCS family adaptor proteins. Semin Immunol 2004; 16: 351-365.
8. Sander M, van Heymann C, von Dossow V, et al: Increased interleukin-6 after cardiac surgery predicts infection. Anesth Analg 2006; 102: 1623-1629.
9. Pappalardo F, Franco A, Landoni G, et al: Long-term outcome and quality of life of patients requiring prolonged mechanical ventilation after cardiac surgery. Eur J Cardiothorac Surg 2004; 25: 548-552.
10. Hein OV, Birnbaum J, Wernecke K, et al: Prolonged intensive care unit stay in cardiac surgery: risk factors and long-term survival. Ann Thorac Surg 2001; 81: 880-885.
11. Roy S, Loh HH: Effect of opioids on the immune system. Neurochem Res 1996; 21: 1375-1386.
12. Stefano GB, Burrill JD, Labur S, et al: Regulation of various genes in human leukocytes acutely exposed to morphine; expression microarray analysis. Med Sci Monit 2005; 11: MS35-MS42.
13. Roy S, Wang J, Gupta S, et al: Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol 2004; 147: 78-81.
14. Murphy GS, Szokol JW, Marymont JH, et al: The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth Analg 2007; 104: 1334-1342.
15. Engoren M, Luther G, Fenn-Buderer N: A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anethesia. Anesth Analg 2001; 93: 859-864.
16. Johansen JW: Monitoring pharmacologic effects of anesthesia. Curr Anesthesiol Rep 2000; 2: 369-376.
17. Braun J, Grosse J: Standard operating procedures for cardiac anesthesia. In: Check-up Anesthesiology (Kox WJ, Spies C, eds). Berlin: Springer, 2003; A-6, pp 95-132.
18. Calafiore AM, Teodori G, Mezzetti A, et al: Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59: 398-402.
19. Ely EW, Bennett PA, Bowton DL, et al: Large scale implementation of a respiratory therapist-driven protocol for ventilator weaning. Am J Respir Crit Care Med 1999; 159: 439-446.
20. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESCIM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
21. Turner JS, Mudaliar YM, Chang RWS, et al: Acute physiology and chronic health evaluation (APACHE II) scoring in a cardiothoracic intensive care unit. Crit Care Med 1991; 19: 1266-1269.
22. Vincent JL, De Mendonça A, Cantraine F, et al: Use of the SOFA scare to assess the incidence of organ dyfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-1800.
23. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
24. Halle E, Goebel UB, Kastrup M, et al: Antimicrobial therapy. In: Check-up Anesthesiology (Kox WJ, Spies C, eds). Berlin: Springer, 2003; A-15, pp 446-448.
25. Weiss S, Kotsch K, Francuski M, et al: Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007; 7: 1584-1593.
26. -ΔΔCr method. Methods 2001; 25: 402-408.
27. Brunner E, Domhof S, Langer F: Nonparametric Analyst of Longitudinal Data in Factorial Experiments. New York: John Wiley, 2002.
28. Bathke A, Brunner E: A nonparametric alternative to analysis of covariance. In: Recent Advances and Trends in Nonparametric Statistics (Akritos MG, Politis DN, eds). Amsterdam: Elsevier, 2003; pp 109-120.
29. Qian YN, Jin WJ, Wang L, et al: Effect of different concentrations of morphine and tramadol on the differentiation of human helper T cell in vitro. Br J Anaesth 2005; 95: 277.
30. Nair MP, Schwartz SA, Polasani R, et al: Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol 1997; 4: 127-132.
31. Mazarakou G, Georgoussi Z: STATSA interacts with and is phosphorylated upon activation of the μ-opioid receptor. J Neurochem 2005; 93: 918-931.
32. Peterson PK, Sharp B, Gekker G, et al: Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest 1987; 80: 824-831.
33. Yang XP, Schaper F, Teubner A, et al: Interleukin-6 plays a crucial role in the hepatic expression of SOCS-3 during acute inflammation processes in vivo. J Hepatol 2005; 43: 704-710.
34. Adamik B, Kuebler-Kielb J, Golebiowska B, et al: Effect of sepsis and cardac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000; 26: 1259-1267.
35. Sablotzki A, Dehne MG, Friedrich I, et al: Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery. Eur J Med Res 2003; 8: 71-76.
36. Dandona P, Nix D, Wilson MF, et al: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-1608.